"Dosage Forms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect.
Descriptor ID |
D004304
|
MeSH Number(s) |
D26.255 E05.916.250
|
Concept/Terms |
Dosage Forms- Dosage Forms
- Dosage Form
- Form, Dosage
- Forms, Dosage
|
Below are MeSH descriptors whose meaning is more general than "Dosage Forms".
Below are MeSH descriptors whose meaning is more specific than "Dosage Forms".
This graph shows the total number of publications written about "Dosage Forms" by people in this website by year, and whether "Dosage Forms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2014 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dosage Forms" by people in Profiles.
-
Interprofessional pharmacy observation activity for third-year dental students. J Dent Educ. 2014 Sep; 78(9):1313-8.
-
Influence of a systems-based approach to prescribing errors in a pediatric resident clinic. Acad Pediatr. 2014 Sep-Oct; 14(5):485-90.
-
OTC product: maximum strength Zantac 150. J Am Pharm Assoc (2003). 2005 Jul-Aug; 45(4):528.
-
Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn. Aliment Pharmacol Ther. 2002 Mar; 16(3):435-43.
-
Mononitrates: defining the ideal long-acting nitrate. Clin Ther. 1994 Mar-Apr; 16(2):130-9; discussion 129.